Risk-benefit value of inhaled corticosteroids: a pharmacokinetic/pharmacodynamic perspective.
Rohatagi
Shashank
S
Aventis Pharmaceuticals, Bridgewater, NJ 08807-0800, USA. shashank.rohatagi@aventis.com
Derendorf
Hartmut
H
Zech
Karl
K
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D018570:Risk Assessment
D000305:Adrenal Cortex Hormones